T1	AdverseReaction 112 139	Application-Associated Pain
T2	AdverseReaction 188 214	Increase in Blood Pressure
T3	AdverseReaction 347 372	application site erythema
T4	AdverseReaction 374 395	application site pain
T5	AdverseReaction 397 422	application site pruritus
T6	AdverseReaction 427 451	application site papules
T7	AdverseReaction 1552 1577	application site erythema
T8	AdverseReaction 1579 1600	application site pain
T9	AdverseReaction 1602 1627	application site pruritus
T10	AdverseReaction 1632 1656	application site papules
T11	AdverseReaction 1888 1914	application site reactions
T12	Severity 1920 1929	transient
T13	AdverseReaction 1958 1975	increases in pain
T14	Severity 1948 1957	Transient
T15	AdverseReaction 2057 2071	Pain increases
T17	AdverseReaction 2868 2893	Application Site Erythema
T18	AdverseReaction 2977 2998	Application Site Pain
T19	AdverseReaction 3086 3111	Application Site Pruritus
T20	AdverseReaction 3195 3219	Application Site Papules
T21	AdverseReaction 3304 3326	Application Site Edema
T22	AdverseReaction 3413 3438	Application Site Swelling
T23	AdverseReaction 3522 3546	Application Site Dryness
T24	AdverseReaction 3740 3755	Nasopharyngitis
T25	AdverseReaction 3849 3859	Bronchitis
T26	AdverseReaction 3958 3967	Sinusitis
T27	AdverseReaction 4176 4182	Nausea
T28	AdverseReaction 4285 4293	Vomiting
T29	AdverseReaction 4503 4511	Pruritus
T30	AdverseReaction 4721 4733	Hypertension
T31	AdverseReaction 4974 5000	Application site urticaria
T32	AdverseReaction 5002 5030	Application site paresthesia
T33	AdverseReaction 5032 5059	Application site dermatitis
T34	AdverseReaction 5061 5091	Application site hyperesthesia
T35	AdverseReaction 5093 5121	Application site excoriation
T36	AdverseReaction 5123 5146	Application site warmth
T37	AdverseReaction 5148 5175	Application site anesthesia
T38	AdverseReaction 5177 5202	Application site bruising
T39	AdverseReaction 5204 5233	Application site inflammation
T40	AdverseReaction 5235 5263	Application site exfoliation
T41	AdverseReaction 5265 5281	Peripheral edema
T42	AdverseReaction 5312 5320	Headache
T43	AdverseReaction 5322 5339	Burning sensation
T44	AdverseReaction 5341 5370	Peripheral sensory neuropathy
T45	AdverseReaction 5372 5381	Dizziness
T46	AdverseReaction 5383 5392	Dysgeusia
T47	AdverseReaction 5394 5407	Hyperesthesia
T48	AdverseReaction 5409 5421	Hypoesthesia
T49	AdverseReaction 5475 5480	Cough
T50	AdverseReaction 5482 5499	Throat irritation
T51	AdverseReaction 5544 5562	Abnormal skin odor
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11 Effect:E12
E12	Severity:T12
E13	AdverseReaction:T11
E14	AdverseReaction:T13 Effect:E15
E15	Severity:T14
E16	AdverseReaction:T15
E18	AdverseReaction:T17
E19	AdverseReaction:T18
E20	AdverseReaction:T19
E21	AdverseReaction:T20
E22	AdverseReaction:T21
E23	AdverseReaction:T22
E24	AdverseReaction:T23
E25	AdverseReaction:T24
E26	AdverseReaction:T25
E27	AdverseReaction:T26
E28	AdverseReaction:T27
E29	AdverseReaction:T28
E30	AdverseReaction:T29
E31	AdverseReaction:T30
E32	AdverseReaction:T31
E33	AdverseReaction:T32
E34	AdverseReaction:T33
E35	AdverseReaction:T34
E36	AdverseReaction:T35
E37	AdverseReaction:T36
E38	AdverseReaction:T37
E39	AdverseReaction:T38
E40	AdverseReaction:T39
E41	AdverseReaction:T40
E42	AdverseReaction:T41
E43	AdverseReaction:T42
E44	AdverseReaction:T43
E45	AdverseReaction:T44
E46	AdverseReaction:T45
E47	AdverseReaction:T46
E48	AdverseReaction:T47
E49	AdverseReaction:T48
E50	AdverseReaction:T49
E51	AdverseReaction:T50
E52	AdverseReaction:T51
A1	CUI E1 C0521491
A2	UMLS-Preferred-Name E1 Application site pain
A3	MEDDRA-PT E1 Application site pain
A4	MEDDRA-PT-ID E1 10003051
A5	LLT E1 Pain after application
A6	LLT-ID E1 10033375
A7	CUI E2 C0497247
A8	UMLS-Preferred-Name E2 Increase in blood pressure
A9	MEDDRA-PT E2 Blood pressure increased
A10	MEDDRA-PT-ID E2 10005750
A11	CUI E3 C0853700
A12	UMLS-Preferred-Name E3 Application site erythema
A13	MEDDRA-PT E3 Application site erythema
A14	MEDDRA-PT-ID E3 10003041
A15	CUI E4 C0521491
A16	UMLS-Preferred-Name E4 Application site pain
A17	MEDDRA-PT E4 Application site pain
A18	MEDDRA-PT-ID E4 10003051
A19	CUI E5 C0853714
A20	UMLS-Preferred-Name E5 Application site pruritus
A21	MEDDRA-PT E5 Application site pruritus
A22	MEDDRA-PT-ID E5 10003053
A23	CUI E6 C0877127
A24	UMLS-Preferred-Name E6 Application site papules
A25	MEDDRA-PT E6 Application site papules
A26	MEDDRA-PT-ID E6 10049043
A27	CUI E7 C0853700
A28	UMLS-Preferred-Name E7 Application site erythema
A29	MEDDRA-PT E7 Application site erythema
A30	MEDDRA-PT-ID E7 10003041
A31	CUI E8 C0521491
A32	UMLS-Preferred-Name E8 Application site pain
A33	MEDDRA-PT E8 Application site pain
A34	MEDDRA-PT-ID E8 10003051
A35	CUI E9 C0853714
A36	UMLS-Preferred-Name E9 Application site pruritus
A37	MEDDRA-PT E9 Application site pruritus
A38	MEDDRA-PT-ID E9 10003053
A39	CUI E10 C0877127
A40	UMLS-Preferred-Name E10 Application site papules
A41	MEDDRA-PT E10 Application site papules
A42	MEDDRA-PT-ID E10 10049043
A43	CUI E11 C0151505
A44	UMLS-Preferred-Name E11 Application site reaction
A45	MEDDRA-PT E11 Application site reaction
A46	MEDDRA-PT-ID E11 10003055
A47	CUI E14 C0853946
A48	UMLS-Preferred-Name E14 Pain worsened
A49	MEDDRA-PT E14 Pain
A50	MEDDRA-PT-ID E14 10033371
A51	LLT E14 Exacerbation of pain
A52	LLT-ID E14 10015579
A53	CUI E16 C0853946
A54	UMLS-Preferred-Name E16 Pain worsened
A55	MEDDRA-PT E16 Pain
A56	MEDDRA-PT-ID E16 10033371
A57	LLT E16 Pain worsened
A58	LLT-ID E16 10033499
A59	CUI E18 C0853700
A60	UMLS-Preferred-Name E18 Application site erythema
A61	MEDDRA-PT E18 Application site erythema
A62	MEDDRA-PT-ID E18 10003041
A63	CUI E19 C0521491
A64	UMLS-Preferred-Name E19 Application site pain
A65	MEDDRA-PT E19 Application site pain
A66	MEDDRA-PT-ID E19 10003051
A67	CUI E20 C0853714
A68	UMLS-Preferred-Name E20 Application site pruritus
A69	MEDDRA-PT E20 Application site pruritus
A70	MEDDRA-PT-ID E20 10003053
A71	CUI E21 C0877127
A72	UMLS-Preferred-Name E21 Application site papules
A73	MEDDRA-PT E21 Application site papules
A74	MEDDRA-PT-ID E21 10049043
A75	CUI E22 C0234936
A76	UMLS-Preferred-Name E22 Application site edema
A77	MEDDRA-PT E22 Application site oedema
A78	MEDDRA-PT-ID E22 10003050
A79	LLT E22 Application site edema
A80	LLT-ID E22 10003040
A81	CUI E23 C1096001
A82	UMLS-Preferred-Name E23 Application site swelling
A83	MEDDRA-PT E23 Application site swelling
A84	MEDDRA-PT-ID E23 10053424
A85	CUI E24 C0877098
A86	UMLS-Preferred-Name E24 Application site dryness
A87	MEDDRA-PT E24 Application site dryness
A88	MEDDRA-PT-ID E24 10048943
A89	CUI E25 C0027441
A90	UMLS-Preferred-Name E25 Nasopharyngitis
A91	MEDDRA-PT E25 Nasopharyngitis
A92	MEDDRA-PT-ID E25 10028810
A93	CUI E26 C0006277
A94	UMLS-Preferred-Name E26 Bronchitis
A95	MEDDRA-PT E26 Bronchitis
A96	MEDDRA-PT-ID E26 10006451
A97	CUI E27 C0037199
A98	UMLS-Preferred-Name E27 Sinusitis
A99	MEDDRA-PT E27 Sinusitis
A100	MEDDRA-PT-ID E27 10040753
A101	CUI E28 C0027497
A102	UMLS-Preferred-Name E28 Nausea
A103	MEDDRA-PT E28 Nausea
A104	MEDDRA-PT-ID E28 10028813
A105	CUI E29 C0042963
A106	UMLS-Preferred-Name E29 Vomiting
A107	MEDDRA-PT E29 Vomiting
A108	MEDDRA-PT-ID E29 10047700
A109	CUI E30 C0033774
A110	UMLS-Preferred-Name E30 Pruritus
A111	MEDDRA-PT E30 Pruritus
A112	MEDDRA-PT-ID E30 10037087
A113	CUI E31 C0020538
A114	UMLS-Preferred-Name E31 Hypertensive disease
A115	MEDDRA-PT E31 Hypertension
A116	MEDDRA-PT-ID E31 10020772
A117	CUI E32 C0919603
A118	UMLS-Preferred-Name E32 Application site urticaria
A119	MEDDRA-PT E32 Application site urticaria
A120	MEDDRA-PT-ID E32 10050104
A121	CUI E33 C0877096
A122	UMLS-Preferred-Name E33 Application site paraesthesia
A123	MEDDRA-PT E33 Application site paraesthesia
A124	MEDDRA-PT-ID E33 10050103
A125	LLT E33 Application site paresthesia
A126	LLT-ID E33 10048940
A127	CUI E34 C0521495
A128	UMLS-Preferred-Name E34 Application site rash
A129	MEDDRA-PT E34 Application site dermatitis
A130	MEDDRA-PT-ID E34 10003036
A131	CUI E35 C0919600
A132	UMLS-Preferred-Name E35 Application site hyperaesthesia
A133	MEDDRA-PT E35 Application site hyperaesthesia
A134	MEDDRA-PT-ID E35 10050100
A135	LLT E35 Application site hyperesthesia
A136	LLT-ID E35 10054328
A137	CUI E36 C1142498
A138	UMLS-Preferred-Name E36 Application site excoriation
A139	MEDDRA-PT E36 Application site erosion
A140	MEDDRA-PT-ID E36 10065577
A141	LLT E36 Application site excoriation
A142	LLT-ID E36 10059006
A143	CUI E37 C0858794
A144	UMLS-Preferred-Name E37 Application site warmth
A145	MEDDRA-PT E37 Application site warmth
A146	MEDDRA-PT-ID E37 10003060
A147	CUI E38 C0234943
A148	UMLS-Preferred-Name E38 Application site anesthesia
A149	MEDDRA-PT E38 Application site anaesthesia
A150	MEDDRA-PT-ID E38 10003033
A151	LLT E38 Application site anesthesia
A152	LLT-ID E38 10003034
A153	CUI E39 C0877095
A154	UMLS-Preferred-Name E39 Application site haematoma
A155	MEDDRA-PT E39 Application site bruise
A156	MEDDRA-PT-ID E39 10050114
A157	LLT E39 Application site bruising
A158	LLT-ID E39 10048939
A159	CUI E40 C0877126
A160	UMLS-Preferred-Name E40 Application site inflammation
A161	MEDDRA-PT E40 Application site inflammation
A162	MEDDRA-PT-ID E40 10049042
A163	CUI E41 C1610049
A164	UMLS-Preferred-Name E41 Application site exfoliation
A165	MEDDRA-PT E41 Application site exfoliation
A166	MEDDRA-PT-ID E41 10064578
A167	CUI E42 C0085649
A168	UMLS-Preferred-Name E42 Peripheral edema
A169	MEDDRA-PT E42 Oedema peripheral
A170	MEDDRA-PT-ID E42 10030124
A171	LLT E42 Peripheral edema
A172	LLT-ID E42 10034570
A173	CUI E43 C0018681
A174	UMLS-Preferred-Name E43 Headache
A175	MEDDRA-PT E43 Headache
A176	MEDDRA-PT-ID E43 10019211
A177	CUI E44 C0085624
A178	UMLS-Preferred-Name E44 Burning sensation
A179	MEDDRA-PT E44 Burning sensation
A180	MEDDRA-PT-ID E44 10006784
A181	CUI E45 C0151313
A182	UMLS-Preferred-Name E45 Sensory neuropathy
A183	MEDDRA-PT E45 Peripheral sensory neuropathy
A184	MEDDRA-PT-ID E45 10034620
A185	CUI E46 C0012833
A186	UMLS-Preferred-Name E46 Dizziness
A187	MEDDRA-PT E46 Dizziness
A188	MEDDRA-PT-ID E46 10013573
A189	CUI E47 C0013378
A190	UMLS-Preferred-Name E47 Dysgeusia
A191	MEDDRA-PT E47 Dysgeusia
A192	MEDDRA-PT-ID E47 10013911
A193	CUI E48 C0020453
A194	UMLS-Preferred-Name E48 Hyperesthesia
A195	MEDDRA-PT E48 Hyperaesthesia
A196	MEDDRA-PT-ID E48 10020568
A197	LLT E48 Hyperesthesia
A198	LLT-ID E48 10020622
A199	CUI E49 C0020580
A200	UMLS-Preferred-Name E49 Hypesthesia
A201	MEDDRA-PT E49 Hypoaesthesia
A202	MEDDRA-PT-ID E49 10020937
A203	LLT E49 Hypoesthesia
A204	LLT-ID E49 10020976
A205	CUI E50 C0010200
A206	UMLS-Preferred-Name E50 Coughing
A207	MEDDRA-PT E50 Cough
A208	MEDDRA-PT-ID E50 10011224
A209	CUI E51 C0700184
A210	UMLS-Preferred-Name E51 Throat irritation
A211	MEDDRA-PT E51 Throat irritation
A212	MEDDRA-PT-ID E51 10043521
A213	CUI E52 C0234930
A214	UMLS-Preferred-Name E52 Skin odour abnormal
A215	MEDDRA-PT E52 Skin odour abnormal
A216	MEDDRA-PT-ID E52 10040904
A217	LLT E52 Skin odor abnormal
A218	LLT-ID E52 10040903
